| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 |
| filingDate |
2000-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bb6d1e072ab01923f4969a96545cd4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dca37afba0ceaeb37820196a49971475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_552fa3536cf3f2ec8ad99481583a49ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3b8fba9264877987ca8967cb61279c4 |
| publicationDate |
2007-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BG-65116-B1 |
| titleOfInvention |
PHARMACEUTICAL FORM WITH CONTROLLED RELEASE, SOLVABLE MAJOR MEDICINAL PRODUCTS |
| abstract |
The controlled release solid pharmaceutical composition is intended for oral administration at a reduced daily dosage. The therapeutic ingredient is a poorly soluble basic drug. The pharmaceutical form comprises a water-soluble alginate salt, a complex salt of alginic acid and an organic carboxylic acid mixed with the therapeutic drug. A more specific embodiment of the invention comprises a once-daily dosage form of clarithromycin. |
| priorityDate |
2000-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |